At the time of writing, Kalaris Therapeutics Inc [KLRS] stock is trading at $10.42, saw in change for the day. In order to assess the stock’s recent performance, you can check whether its short-term value is rising or falling. The KLRS shares have gain 25.09% over the last week, with a monthly amount glided 61.55%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Kalaris Therapeutics Inc [NASDAQ: KLRS] stock has seen the most recent analyst activity on November 03, 2025, when Citizens JMP initiated its Mkt Outperform rating and assigned the stock a price target of $20. Previously, Raymond James started tracking the stock with Strong Buy rating on September 03, 2025, and set its price target to $23. Leerink Partners started tracking the stock assigning a Outperform rating and suggested a price target of $20 on May 07, 2025. William Blair initiated its recommendation with a Outperform.
For the past year, the stock price of Kalaris Therapeutics Inc fluctuated between $2.14 and $12.90. Currently, Wall Street analysts expect the stock to reach $3 within the next 12 months. Kalaris Therapeutics Inc [NASDAQ: KLRS] shares were valued at $10.42 at the most recent close of the market. An investor can expect a potential drop of -71.21% based on the average KLRS price forecast.
Analyzing the KLRS fundamentals
To continue investigating profitability, this company’s Return on Assets is posted at -0.64, Equity is -0.76 and Total Capital is -0.73. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.04.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 9.64 points at the first support level, and at 8.86 for the second support level. However, for the 1st resistance point, the stock is sitting at 11.54, and for the 2nd resistance point, it is at 12.66.
Ratios To Look Out For
It is important to note that Kalaris Therapeutics Inc [NASDAQ:KLRS] has a current ratio of 12.89. In addition, the Quick Ratio stands at 12.89 and the Cash Ratio stands at 6.99.
Transactions by insiders
Recent insider trading involved Hagen Brett R, Chief Accounting Officer, that happened on Mar 26 ’25 when 907.0 shares were sold.
